Graduate Student Summer Seminar Series
August 8, 2014
"Homomorphic Histone Variant HIST1H2BE and Endocrine Resistant Breast Cancer"
Advisor: Steffi Oesterreich, PhD
"Therapeutic actions of electrophilic nitroalkenes via inhibition of the NFkB pathway in triple negative breast cancer"
Chen Shan (Julia) Woodcock
Advisor: Bruce Freeman, PhD
Ed Levitan, NIH R21 DA038384, 6/15/14-5/31/16, $423,500
Jean-Pierre Vilardaga, NIH R01 DK102495, 7/1/14-5/31/18, $1,953,508
Matthew Hedberg, NIH F30 CA180235, 07/14-04/18, $168,130
PhD Dissertation Defense and Final Examination
Monday, August 18, 2014
1395 Thomas E. Starzl Biomedical Science Tower
"Rational Design and Therapeutic Potential of a Novel Nox1 Inhibitor for the Treatment of Pulmonary Hypertension: In Vitro and In Vivo Effects of Nox1 Inhibition"
Daniel Jacob Ranayhossaini
Celebrating fifty years of excellence in research, education, and training
Finegersh PLOS ONE paper featured in Science Daily
Dad's alcohol consumption before conception could influence sons' drinking
See all posts
Back to Top